Evidence map›Paper›PMID 23748383›Full record

ArticlePsychopharmacology2013

Methamphetamine-induced increases in putamen gray matter associate with inhibitory control.

Stephanie M Groman, Angelica M Morales, Buyean Lee, Edythe D London, James David Jentsch

Abstract read
In one paragraph

Article in Psychopharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Neural circuitry and mechanisms of waiting impulsivity: relevance to addiction.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2019
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Brain Microstructure and Impulsivity Differ between Current and Past Methamphetamine Users.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Stephanie M GromanDepartment of Psychology, UCLA Department of Psychology, PO Box 951563, Los Angeles, CA, 90095-1563, USA.
Angelica M Morales
Buyean Lee
Edythe D London
James David Jentsch
University of California, Los Angeles · USNeurobehavioral Systems · US

Funding

UCLA Training Program in Translational Neuroscience of Drug Abuse (TNDA)T32DA024635 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LARA A. RAY, Kate M Wassum · 2008 to 2026
$6.2M
NEUROCHEMISTRY OF MODAFINIL-MA INTERACTION IN RAT BRAINP20DA022539 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LONDON, EDYTHE DANICK · 2006 to 2009
$2.9M
Translational Models of Memory and Cognitive Control (Component 5 of 8)RL1MH083270 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JENTSCH, J. DAVID · 2007 to 2011
$2.6M
Consortium for Neuropsychiatric Phenomics-Coordinating Center (1 of 8)UL1DE019580 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BILDER, ROBERT M · 2008 to 2011
$1.9M
Vervet Monkey Model for Methamphetamine-Induced Deficits in Response InhibitionR03DA020598 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LEE, BUYEAN · 2005 to 2005
$232k
Impulsivity and D2 Receptor Function: Behavioral and PET CorrelatesF31DA028812 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GROMAN, STEPHANIE MARY · 2010 to 2012
$100k
Neural substrates of impulsive behavior in methamphetamine dependenceF31DA033117 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MORALES, ANGELICA MARIE · 2012 to 2013
$70k
NIDA NIH HHS F31 DA028812NIDA NIH HHS F31-DA028812NIDA NIH HHS F31 DA033117NIDA NIH HHS F31-DA033117NIDA NIH HHS P20 DA022539NIDA NIH HHS P20-DA022539NIDA NIH HHS R03 DA020598NIDA NIH HHS R03-DA020598NIDA NIH HHS T32 DA024635NIDA NIH HHS T32-DA024635NIDCR NIH HHS UL1 DE019580NIDCR NIH HHS UL1-DE019580NIMH NIH HHS RL1 MH083270NIMH NIH HHS RL1-MH083270
6 · The paper itself

Abstract

rationaleProblematic drug use is associated with difficulty in exerting self-control over behaviors, and this difficulty may be a consequence of atypical morphometric characteristics that are exhibited by drug-experienced individuals. The extent to which these structural abnormalities result from drug use or reflect neurobiological risk factors that predate drug use, however, is unknown.

objectivesThe purpose of this study is to determine how methamphetamine affects corticostriatal structure and how drug-induced changes relate to alterations in inhibitory control.

methodsStructural magnetic resonance images and positron emission tomography (PET) scans, assessing dopamine D₂-like receptor and transporter availability, were acquired in monkeys trained to acquire, retain, and reverse three-choice visual discrimination problems before and after exposure to an escalating dose regimen of methamphetamine (or saline, as a control). Voxel-based morphometry was used to compare changes in corticostriatal gray matter between methamphetamine- and saline-exposed monkeys. The change in gray matter before and after the dosing regimen was compared to the change in the behavioral performance and in dopaminergic markers measured with PET.

resultsMethamphetamine exposure, compared to saline, increased gray matter within the right putamen. These changes were positively correlated with changes in performance of methamphetamine-exposed monkeys in the reversal phase, and were negatively correlated with alterations in D₂-like receptor and DAT availability.

conclusionsThe results provide the first evidence that exposure to a methamphetamine dosing regimen that resembles human use alters the structural integrity of the striatum and that gray-matter abnormalities detected in human methamphetamine users are due, at least in part, to the pharmacological effects of drug experience.

Indexed as

Inhibition, PsychologicalAmphetamine-Related DisordersAnimalsChlorocebus aethiopsCognitionDiscrimination, PsychologicalDose-Response Relationship, DrugMagnetic Resonance ImagingMaleMethamphetaminePositron-Emission TomographyPutamenReceptors, Dopamine D2Retention, PsychologyReversal LearningTime FactorsMethamphetamineReceptors, Dopamine D2

Identifiers

PMID23748383
PMCPMC3770792
OpenAlexW2055993736

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.